找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Atlas of Hepatocellular Carcinoma Pathology; Haeryoung Kim,Wei-Qiang Leow,Anthony Wing-Hung Cha Book 2022 The Editor(s) (if applicable) an

[復(fù)制鏈接]
樓主: Radiofrequency
41#
發(fā)表于 2025-3-28 16:36:44 | 只看該作者
42#
發(fā)表于 2025-3-28 21:17:33 | 只看該作者
Precursor Lesions of Hepatocellular Carcinoma,rcinogenesis may also occur in non-cirrhotic livers, some cases resulting from the malignant transformation of hepatocellular adenomas. This chapter summarises and illustrates the histopathological features of the various precancerous lesions of HCC.
43#
發(fā)表于 2025-3-29 02:50:00 | 只看該作者
44#
發(fā)表于 2025-3-29 04:19:53 | 只看該作者
Hammering Floating-Point Arithmeticgnised as a histopathological variant of HCC in the current WHO classification; however, there is accumulating data on the aggressive clinicopathological features and prognostic implications of this tumour, and hence CK19-expression HCC is discussed separately in this chapter.
45#
發(fā)表于 2025-3-29 08:00:14 | 只看該作者
46#
發(fā)表于 2025-3-29 14:18:53 | 只看該作者
47#
發(fā)表于 2025-3-29 15:39:28 | 只看該作者
Differential Diagnoses of Hepatocellular Carcinoma,nature of the lesion and the status of the non-tumourous liver. This chapter provides a brief non-exhaustive overview of various differential diagnoses and highlights useful diagnostic clues through various case studies.
48#
發(fā)表于 2025-3-29 21:01:11 | 只看該作者
49#
發(fā)表于 2025-3-30 01:41:55 | 只看該作者
Guilherme V. Toledo,Yoni Zohar,Clark Barrettarcelona Clinic Liver Cancer (BCLC) are two major systems widely used in daily practice worldwide and will be briefly discussed in this chapter. A new emerging system, Hong Kong Liver Cancer (HKLC), incorporating both prognostic information and treatment recommendation will also be mentioned here.
50#
發(fā)表于 2025-3-30 04:26:42 | 只看該作者
Tumour Staging for Hepatocellular Carcinoma,arcelona Clinic Liver Cancer (BCLC) are two major systems widely used in daily practice worldwide and will be briefly discussed in this chapter. A new emerging system, Hong Kong Liver Cancer (HKLC), incorporating both prognostic information and treatment recommendation will also be mentioned here.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-18 01:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
江阴市| 仁寿县| 阿瓦提县| 武邑县| 建宁县| 潮安县| 乃东县| 淅川县| 宁德市| 永城市| 略阳县| 兰考县| 孙吴县| 咸阳市| 广州市| 稷山县| 凤翔县| 山阳县| 蓬莱市| 沅陵县| 房山区| 泌阳县| 淅川县| 永顺县| 长葛市| 镇安县| 屏东市| 淮安市| 黎平县| 锡林浩特市| 彰化县| 阳信县| 凯里市| 张家口市| 津南区| 义乌市| 吉首市| 汝州市| 垦利县| 湘阴县| 工布江达县|